Association of Thyroid Function With Restenosis and Long-Term Outcomes After Drug-Coated Balloon Angioplasty in Euthyroid Patients With Coronary Heart Disease. [PDF]
Duan Y +6 more
europepmc +1 more source
Intravascular imaging-guided drug-coated balloon treatment for coronary artery disease:Evidence and practice. [PDF]
Gawalkar AA, Mintz GS, Naik N.
europepmc +1 more source
Three-Year Outcome of Drug Coated Balloon Angioplasty Following Atherectomy for Severely Calcified Coronary Lesions. [PDF]
Takamura TA +11 more
europepmc +1 more source
Safety and feasibility of the treatment of calcified <i>de novo</i> coronary artery lesions with drug-coated balloon angioplasty after intravascular lithotripsy. [PDF]
Räsänen A, Eranti A, Rissanen TT.
europepmc +1 more source
Ultrasound assessment of intimal hyperplasia after plain balloon angioplasty and drug-coated balloon angioplasty of AV access stenosis. [PDF]
Steiner K, Kirwan C, Ramanarayanan S.
europepmc +1 more source
A Comparison of a Drug Coated Balloon With Drug Eluting Stent Strategy for Treating Coronary Bifurcation Lesions. [PDF]
Corballis N +12 more
europepmc +1 more source
Clinical outcomes of drug-coated balloon vs. second-generation drug-eluting stent for coronary in-stent restenosis. [PDF]
Krefting J +20 more
europepmc +1 more source
Outcomes of drug-coated balloon dilation in patients with radiation-related urethral stenosis. [PDF]
Masopeh J +3 more
europepmc +1 more source
Drug-coated balloon with bailout stenting versus drug-eluting stent plus drug-coated balloon in TransAtlantic Inter-Society Consensus C and D femoropopliteal lesions: a propensity score-matched analysis. [PDF]
Chen C +11 more
europepmc +1 more source
Is Paclitaxel Causing Mortality During Lower‐Extremity Revascularization?
Rajesh V. Swaminathan +2 more
doaj +1 more source

